. Author manuscript; available in PMC: 2014 Jul 31.

Published in final edited form as: Biol Blood Marrow Transplant. 2012 Oct 27;19(1 0):S102–S108. doi: 10.1016/j.bbmt.2012.10.028

Table 3.

Matched Cohort Analysis of Tacrolimus/Methotrexate versus Posttransplantation Cyclophosphamide after RIC

	Posttransplantation CY (n = 49), % (95% a)	Tacrolimus and Methotrexate, % (95% CI)	HR (95% CI)	P Value
Acute GVHD grade II-IV	46(32–66)	19 (10–37)	2.8 (1.1–6.7)	.02
Chronic GVHD at 1 year	14 (6–32)	21 (11–43)	0.8 (0.2–2.6)	.70
NRM at 2 years	36 (23–55)	16 (7–35)	2.4 (0.8–6.7)	.10
PFS at 2 years	22 (10–37)	33 (16–51)	1.3 (0.7–23)	.40
OS at 2 years	26 (13–42)	46 (26–64)	1.8 (0.9–33)	.08